Stock SAVARA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. Savara Inc Nyse

Equities

US5763141083

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Savara Inc
Apr. 12 Dr. Ricky Sun Notifies the Board of Directors of Savara Inc. of His Intention Not to Stand for Reelection CI
Apr. 08 Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis at the American Thoracic Society International Conference 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Piper Sandler Adjusts Price Target on Savara to $16 From $7, Maintains Overweight Rating
MT
JMP Securities Starts Savara With Market Outperform Rating, $8 Price Target
MT
Guggenheim Starts Savara With Buy Rating, $7 Price Target
MT
HC Wainwright Adjusts Price Target on Savara to $6 From $3, Keeps Buy Rating
MT
Jefferies Downgrades Savara to Hold From Buy With $2 Price Target
MT
History shows stocks can weather rate hike cycle
RE
SAVARA : Piper Sandler Starts Savara at Overweight With $7 Price Target
MT
SAVARA : Oppenheimer Initiates Savara at Outperform With $4 Price Target
MT
SAVARA : HC Wainwright Adjusts Savara's Price Target to $3 From $6, Keeps at Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SVRA Stock
  4. Stock
  5. News Savara Inc
  6. Analyst Reco.